Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • Aging (Upcoming)
    • Next-Generation Sequencing in Medicine (Jun 2022)
    • New Therapeutic Targets in Cardiovascular Diseases (Mar 2022)
    • Immunometabolism (Jan 2022)
    • Circadian Rhythm (Oct 2021)
    • Gut-Brain Axis (Jul 2021)
    • Tumor Microenvironment (Mar 2021)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Commentaries
    • Concise Communication
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • In-Press Preview
  • Commentaries
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
The central role of SOCS-3 in integrating the neuro-immunoendocrine interface
Christoph J. Auernhammer, Shlomo Melmed
Christoph J. Auernhammer, Shlomo Melmed
Published December 15, 2001
Citation Information: J Clin Invest. 2001;108(12):1735-1740. https://doi.org/10.1172/JCI14662.
View: Text | PDF
Perspective

The central role of SOCS-3 in integrating the neuro-immunoendocrine interface

  • Text
  • PDF
Abstract

Authors

Christoph J. Auernhammer, Shlomo Melmed

×

Figure 1

Options: View larger image (or click on image) Download as PowerPoint
Corticotroph SOCS-3 as an intracellular suppressor of cytokine signaling...
Corticotroph SOCS-3 as an intracellular suppressor of cytokine signaling. Corticotroph SOCS-3 inhibits STAT-dependent POMC gene expression by negatively interfering with LIF-induced activation of the JAK-STAT cascade. In contrast, CRH-induced POMC gene expression is not affected by SOCS-3. LIF stimulation of the corticotroph results in rapid upregulation of SOCS-3 by a STAT-dependent mechanism. Thus, LIF-induced activation of corticotroph POMC gene activation is limited by parallel induction of SOCS-3 expression, rendering the cell resistant to further JAK-STAT activation. On the other hand, autoregulation of STAT-dependent SOCS-3 gene expression and rapid degradation of SOCS-3 protein by the proteasome pathway enable the cell to restore its functional status. LIF and CRH synergistically induce POMC promoter activity. LIF activates POMC promoter activity not only by direct binding of activated STATs, but also indirectly by inducing STAT-dependent expression of transcription factors c-fos and JunB. CRH also induces SOCS3 promoter activity by binding of c-fos and JunB. Thus, CRH indirectly inhibits LIF-induced POMC promoter activation and downregulates the synergistic cross-talk of CRH and LIF on POMC promoter activity. Adapted from ref. 34 and ref. 47 with permission.

Copyright © 2022 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts